drugset / Trial / NCT04083716

A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults

NCT04083716

Phase 1 Completed 15 enrolled Assembly Biosciences
RandomizedCrossoverOpen-labelTreatment

Summary

This study is designed to assess the relative bioavailability of ABI-H2158 tablets (Test Formulation) compared to ABI-H2158 tablets (Reference Formulation). The effect of food on the pharmacokinetics of the Test Formulation will also be evaluated under fed and fasting conditions.

Timeline

Start
2019-09-06
Primary completion
2019-10-05
Completion
2019-10-07

Drugs

EvaluationDrugModalityDoseRoute
Subject ABI-H2158 Unknown